Thapa, Pradeep <br/><br/>
Performance of 177Lu-DOTATATE-based peptide receptor radionuclide therapy in metastatic gastroenteropancreatic neuroendocrine tumor: a multiparametric response evaluation correlating with primary tumor site, tumor proliferation index, and dual tracer imaging characteristics.  [electronic resource] 

 -  Nuclear medicine communications  Oct 2016 
 - 1030-7 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1473-5628 
<br/><br/><label>Standard No.: </label>10.1097/MNM.0000000000000547  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Biomarkers, Tumor--metabolism<br/>Cell Proliferation--radiation effects<br/>Female<br/>Humans<br/>Intestinal Neoplasms--diagnostic imaging<br/>Male<br/>Middle Aged<br/>Neoplasm Grading<br/>Neoplasm Metastasis<br/>Neuroendocrine Tumors--diagnostic imaging<br/>Octreotide--analogs & derivatives<br/>Organometallic Compounds--therapeutic use<br/>Pancreatic Neoplasms--diagnostic imaging<br/>Positron Emission Tomography Computed Tomography<br/>Radioactive Tracers<br/>Receptors, Somatostatin--metabolism<br/>Stomach Neoplasms--diagnostic imaging<br/>Treatment Outcome